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Focal adhesion kinase (FAK) is considered intimately involved in cancer progression. Our previous research has demonstrated that
overexpression of FAK is an early and frequent event in squamous cell carcinomas of the supraglottic larynx, and it is associated with
the presence of metastases in cervical lymph nodes. The purpose of this study was to examine the functional role of FAK in the
progression of head and neck squamous cell carcinomas (HNSCC). To this end, expression of FAK-related nonkinase (FRNK) or
small interfering RNA (siRNA) against FAK was used to disrupt the FAK-induced signal transduction pathways in the HNSCC-derived
SCC40 and SCC38 cell lines. Similar phenotypic effects were observed with the two methodological approaches in both cell lines.
Decreased cell attachment, motility and invasion were induced by FRNK and FAK siRNA, whereas cell proliferation was not impaired.
In addition, increased cell invasion was observed upon FAK overexpression in SCC cells. FRNK expression resulted in a
downregulation of MMP-2 and MMP-9 expression. Interestingly, MMP-2 overexpression in FRNK-expressing cells rescued FRNK
inhibition of cell invasion. This is the first demonstration of a direct rescue of impaired cell invasion by the re-expression of MMP-2 in a
tumour cell type with decreased expression of functional FAK. Collectively, these data reported here support the conclusion that FAK
enhances invasion of HNSCC by promoting both increased cell motility and MMP-2 production, thus providing new insights into
possible therapeutic intervention strategies.
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Head and neck squamous cell carcinoma (HNSCC) is one of the
most common types of human cancer, comprising B50% of all
malignancies in some developing nations. HNSCC is associated
with severe disease- and treatment-related morbidity and has a
5-year survival rate of B50%. This survival rate has remained
largely unchanged in the past three decades (Sankaranarayanan
et al, 1998; Gonzalez-Botas and Vazquez Barro, 2006). A major
determinant of the lethal progression of HNSCC is the spreading of
the malignant cells to regional lymph nodes which represents a
major prognostic indicator (Forastiere et al, 2001). Thus, attempts
to identify the genes involved in metastasis are pivotal for the early
prediction of HNSCC behaviour and development of novel
molecular therapies. However, the identities of molecular
alterations that endow cancer cells with these metastatic functions
are largely unknown.
The process of metastasis consists of sequential and selective
steps including proliferation, motility, invasion, loss of cell–cell
and cell–matrix adhesion, and remodelling of the extra-
cellular matrix. A key factor involved in the control of cell–
extracellular matrix interactions is focal adhesion kinase (FAK), an
intracellular tyrosine kinase protein that is localised to cellular
focal contact sites (Schaller et al, 1992). Initially, phosphorylation
of FAK occurs on its major autophosphorylation site, Tyr397.
Phosphorylation of this tyrosine initiates a cascade of signal
transduction events that result in the phosphorylation of
subsequent tyrosine residues, including Tyr576, Tyr577, Tyr861 and
Tyr925 which render the molecule a fully active kinase (Schlaepfer
et al, 1999). It is well-established that FAK plays a crucial role in
mediating signal transduction pathways initiated either at the sites
of cell attachment or at growth factor receptors (Sieg et al, 2000).
Its activation leads to a number of cell biological processes,
including cell attachment, migration, invasion, proliferation and
survival which are crucial for cancer development and metastasis
(Gabarra-Niecko et al, 2003; McLean et al, 2005). A large number
of reports describe an enhanced expression of FAK protein in a
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variety of human cancers, including sarcomas, astrocytomas and
carcinomas of the breast, colon, thyroid, prostate, oral cavity, liver,
stomach and ovary (see (McLean et al, 2005) and references
herein). Furthermore, FAK overexpression has been correlated
with the invasive potential of a tumour and poor patient prognosis
(Cance et al, 2000; Miyazaki et al, 2003; Recher et al, 2004; Sood
et al, 2004). In a study of 106 matched pairs of larynx carcinomas
and corresponding normal tissue, using immunohistochemistry,
we have previously shown a significantly increased expression of
FAK at the protein level in both the tumour tissues and the
corresponding metastasis (Canel et al, 2006). Strikingly, we also
found that the FAK expression levels of the primary metastatic
tumors were maintained in their corresponding lymph node
metastases, and FAK protein overexpression in primary tumors
correlates with nodal metastasis. These data suggest that
the deregulation of FAK in HNSCC may have an active role in
the development of distant metastasis to lymph nodes.
In the present report, we address whether FAK expression or
activity in two HNSCC-derived cell lines (SCC40 and SCC38)
contributes to important aspects of HNSCC tumorigenesis such as
growth, cell motility or invasion. The expression of FAK-related
nonkinase (FRNK) or small interfering RNA against FAK (siRNA)
were used to disrupt the FAK-mediated signal transduction
pathways in SCC cells. Exogenous expression of FRNK has been
widely used as a dominant-negative mutant to inhibit FAK
signalling (Schlaepfer et al, 2004). FRNK comprises the C-terminal
region of FAK and promotes FAK tyrosine dephosphorylation
most likely by the competitive displacement of FAK from integrin-
containing focal contacts. The two methodological approaches
yielded similar conclusions. We show that inhibition of FAK-
signalling in SCC40 and SCC38 cells induced decreased cell
attachment, motility and invasion. Furthermore, inhibition of FAK
activity also led to decreased MMP-2 gene expression that was
associated with the selective loss of the invasive cell phenotype.
These data support the conclusion that FAK enhances in vitro cell
invasion activity, at least in part, by promoting both increased cell
motility and MMP-2 production.
MATERIALS AND METHODS
Cell culture
The established human HNSCC-derived cell lines SCC-40 and
SCC38 were kindly provided by Dr R Grenman (Department of
Otolaryngology, University Central Hospital, Turku, Finland).
Cells were grown as previously described (Canel et al, 2006).
Transient transfections, generation of FRNK-expression
construct and stable SCC40 and SCC38 cell lines
Transient transfections were performed in SCC cells using Fugene
6 (Roche Applied Science, Indianapolis, IN, USA) and following
manufacturer’s instructions.
The full-length cDNA coding for FRNK was cloned into the
BamHI/SalI restriction sites of the retroviral vector pWZL.
Phoenix-Ampho packaging cells were transfected with the FRNK-
expression plasmid or empty vector using Fugene (Roche) in
antibiotic-free media. The virus-containing media were collected
48 h posttransfection and immediately used to infect SCC40 and
SCC38 cells. Cells were infected at a density of 1 106 cells ml1 for
48 h in the presence of 4 mg ml1 of polybrene. The infection
procedure was repeated after 24 h. Forty-eight hours after the
second infection, 350 mg ml1 of hygromycin was added to the
culture medium for selection of infected cells. After 10 days of
selection, pooled populations of cells were grown in culture
medium with 25 mg ml1 of antibiotic. The hygromycin selective
pressure was removed 24 h before experimental procedures. FRNK
expression in transfected pool was monitored by western blot
analysis and real time PCR.
Stable populations of FRNK-SCC40 cells were stably transfected
with pcDNA3-human MMP-2 plasmid. FRNK-SCC40 and -SCC38
cells were also stably transfected with either pCEP-Puro-MMP-2 or
pCEP-Puro-mutMMP-2. mutMMP-2 is a catalytically inactive form
of MMP-2 described in (Hauck et al, 2002). Selection was
performed with 350 mg ml1 of G418 (for cells transfected with
pcDNA3-MMP-2 plasmid) or 180mg ml1 of puromycin (for cells
transfected with pCEP-Puro-MMP-2 or pCEP-Puro-mutMMP-2
plasmids) for 10 days. Stable pooled populations of FRNK-MMP-2
cells were maintained in culture using 20 mg ml1 of G418 or
puromycin.
siRNA treatment
siRNA duplex oligonucleotides were purchased from Dharmacon
Research (Lafayette, CO, USA). The targeted sequences for FAK
siRNAs were: GAUAGUGGACAGUCACAAA, CCAGUUUACU
GAAGAUAAG, UUUCUUCUAUCAACAGGUG. siCONTROL Non-
targeting pool (Dharmacon) were used as control siRNA. SCC40
and SCC38 cells were transfected with 35 pmol ml1 siRNAs using
Lipofectamine 2000. Protein analyses revealed a substantial
inhibition of FAK expression 48–72 h after transfection. The
transfected cells were used for subsequent experiments within that
interval of time.
Confocal immunofluorescence microscopy
SCC-40 cells were transiently transfected with pEGFP-FRNK
plasmid and grown on BD Falcon culture slides. Cells were then
fixed in TBS with 3.7% paraformaldehyde and permeabilised by
incubation with TBS containing 0.5% Triton X-100 and 1% bovine
serum albumin for 15 min. After blocking with 5% fetal bovine
serum in TBS for 1 h, SCC40 cells transiently transfected with
pEGFP-FRNK were incubated with phalloidin-TRITC at 1 : 100
dilution for 40 min for actin organisation. pWZL- and FRNK-
SCC40 cells were incubated with rabbit anti-vinculin (Sigma) and
mouse anti-FAK (Becton-Dickinson) at 1 : 100 dilutions for 16 h at
41C, and then washed in phosphate-buffered saline (PBS) and
incubated with CYt2-conjugated anti-mouse and CYt3-conju-
gated anti-rabbit IgG. After washings in TBS/0.025%
Tween-80, cells were examined using a confocal microscope (Leica
TCS-SP2-AOBS).
MTS-based cell proliferation assay
MTS assays were performed using CellTiter 96 Cell NonRadio-
active Proliferation Assay following the protocol recommended by
the manufacturer (Promega, Madison, WI, USA). Briefly, 1000 cells
were seeded in each well of 96-well plates, and allowed to grow for
48, 72 or 96 h. MTS assay was performed at each time point.
Cell cycle and apoptosis analyses
For cell cycle analysis, we used the Vindelov staining method as
described (Vindelov et al, 1983). Cells (5 105) were stained with
propidium iodide (100 mg ml1) and RNase A (100 mg ml1) for
10 min. Cell cycle distribution was acquired with a Cytomics FC500
flow cytometer (Beckman Coulter). For apoptosis analyses, cells
(5 105) were harvested, washed with PBS, and resuspended in
dual staining solution containing 0.5 mg ml1 of propidium iodide
and 0.2 mg ml1 of FITC-Annexin V (FITC-Annexin V/PI protocol;
Sigma). Cells were then incubated for 10 min at room temperature
in the dark and analysed by flow cytometry within 1 h. All analyses
were performed in triplicate.
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Cell attachment
Cells were harvested by trypsinisation and labelled in culture
medium with 5 mM fluorescent dye (calcein AM, Molecular Probes)
at 371C for 1 h. After washing, cells were resuspended in DMEM,
plated (3 105 cells per well) on a 96-well tissue culture dish
coated with fibronectin, type I collagen, matrigel or poly-HEMA
(Sigma), and incubated for 40 min at 371C. Following incubation,
the unattached cells were rinsed away with PBS. The fluorescence
signal from the adherent cells was measured by using a
fluorescence plate reader (FLEXstationt, Molecular Devices) at
an excitation wavelength of 494 nm and an emission wavelength of
517 nm. All analyses were performed in triplicate.
Wound healing assay
Cells were grown to confluence in 35-mm tissue culture dishes. Cell
monolayers were wounded using a micropipette tip, and floating
cells were removed by extensive washing with DMEM. Photo-
graphs of the wounded area were taken immediately after making
the scratch (0 h time point) and after 20 h to measure the migration
rate of cells into the wounded area. At least 15 different fields were
randomly chosen across the wound length.
Time-lapse video recording of cell motility
Cells were seeded in 6-well plates coated with fibronectin, collagen
or matrigel. The cell linear movements were monitored using an
Axiovert 200 M Zeiss microscope with a  20 objective. Images
were captured at 15-min intervals for 12 h from five different fields
in each well. About 100 individual cells per cell line were analysed
using Tracking Analysis software (Kinetic Imaging). All analyses
were performed in triplicate.
Matrigel invasion assays
In vitro invasion assays were performed by using a 24-well
invasion chamber coated with Matrigel (Becton Dickinson). Cells
were trypsinised, washed with PBS, suspended in DMEM contain-
ing 5% bovine serum albumin (BSA), and plated in the invasion
chamber (3 104 cells per well). The lower chambers were filled
with DMEM containing 5% BSA with either 10% (for SCC40 cells)
or 2.5% fetal bovine serum (for SCC38 cells). After 24 h, the cells
remaining in the upper chamber were removed by scraping,
whereas the cells that invaded through Matrigel were fixed and
stained by using 0.5% crystal violet in methanol. All invading cells
were counted by microscopic visualisation. In the case of SCC38
cells transiently transfected with pcDNA3-MMP-2, invasion
occurred as group of cells and, therefore, quantification was
performed by extracting the crystal violet dye with dimethylsulph-
oxide followed by spectrophotometry at 590 nm. All analyses were
performed in triplicate.
Gelatin zymography
Cells (80% confluent) were incubated in serum-free DMEM at 371C
for at least 18 h. The media were then collected and clarified by
centrifugation to remove cells and debris. Samples were loaded
under nonreducing conditions onto 7.5% SDS–polyacrylamide gel
containing 0.2% (w/v) gelatin. Following electrophoresis, the gels
were washed with 2.5% Triton X-100 to remove SDS followed by
incubation in a developing buffer (20 mM Tris, pH 7.4, 5 mM CaCl2)
overnight at 371C. Gels were stained with Coomassie Brilliant Blue
R-250 and destained. Gelatinase activity was visualised as clear
bands against the blue-stained gelatin background. HT-1080
fibrosarcoma cells-conditioned medium, containing high expres-
sion levels of MMP-2 and MMP-9 proteins, was used as positive
control and migration standards. Three individual experiments
were conducted with independent protein samples.
Western blot analyses
Protein extracts were obtained from SCC40 and SCC38 cells at
80–90% confluence as previously described (Canel et al, 2006).
Equal amounts of proteins were fractionated on SDS–PAGE and
transferred to PVDF membranes. Membranes were probed with
anti-FAK clone 4.47 (Upstate Biotechnology, Lake Placid, NY,
USA); anti-FRNK, anti-paxillin (Becton Dickinson Transduction
Laboratories, Erembodegem, Belgium), anti-pY397 FAK, anti-
pY861 FAK (Biosource, Camarillo, CA, USA); anti-pY118 paxillin
(Cell Signaling Technology Inc.); anti-pY925 FAK or anti-a-tubulin
(Sigma-Aldrich, St Louis, MO, USA) at 1 : 1.000 dilutions. Bound
antibodies were detected using enhanced chemiluminescence
reagent (Amersham Pharmacia Biotech) according to the protocol
of the manufacturer.
Quantitative real-time RT–PCR
Total RNA was isolated from cells as previously described
(Del Toro et al, 2003). First-strand cDNA was synthesised from
2 mg of total RNA using the Superscript first-strand synthesis
system for reverse transcriptase (Invitrogen, Carlsbad, CA, USA)
with random primers according to the manufacturer’s directions.
Real-time PCR was done in an ABI Prism 7500 Sequence Detection
System (Applied Biosystems, Foster City, CA, USA) using SYBR
Green PCR Master mix (Applied Biosystems) and the thermocycler
conditions recommended by the manufacturer. Each sample was
analysed for cyclophilin A to normalise for RNA input amounts
and to perform relative quantification. Primers were designed
using the computer program Primer Express (Applied Biosys-
tems). The primers used were as follows: FAK, forward, 50-CTT
CGGACAGCGTGAGAGAGA-30 and reverse, 50-GACGCATTGTT
AAGGCTTCTTGA-30; MMP-2, forward, 50-TGCTGGAGACAAATT
CTGGAGATA-30 and reverse, 50-GGATCCATTTTCTTCTTCACCT
CAT-30; MMP-9, forward, 50-ACCTCGAACTTTGACAGCGAC-30
and reverse, 50-CAAACTGTATCCTTGGTCCGG-30; cyclophilin,
forward, 50-CATCTGCACTGCCAAGACTGA-30 and reverse, 50-TT
GCCAAACACCACATGCTT-30.
RESULTS
Inhibition of FAK-mediated signalling by expression of
FRNK or siRNA against FAK
We have previously reported that FAK is overexpressed in tumour
tissue samples and cell lines derived from HNSCC (Canel et al,
2006). Here, to analyse the functional significance of FAK in
HNSCC progression, we disrupted the FAK-mediated signal
transduction pathway by expression of the FAK COOH-terminal
domain (FAK-related nonkinase, FRNK) or small interfering RNA
(siRNA) against FAK in the HNSCC-derived SCC40 and SCC38 cell
lines. Among the HNSCC-derived cell lines used in our previous
report (Canel et al, 2006), we have selected SCC40 and SCC38 cells
as systems to study the phenotypic effects of inhibiting FAK,
because they express high levels of FAK and the predominant
location of activated FAK (pTyr397-FAK) is at focal adhesion sites.
Expression of FRNK has been widely used as a dominant-
negative inhibitor of FAK function. To determine whether FRNK
may compete with FAK at focal adhesion site in a HNSCC-derived
cell line, GFP-tagged FRNK was transiently expressed in SCC40
cells. Confocal microscopy images showed that FRNK was localised
to focal contacts, docking sites of actin cytoskeleton to the
extracellular matrix (Figure 1A). Therefore, FRNK is likely to
function as an inhibitor of FAK signalling in SCC40 cells.
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We next established stable pool populations of FRNK- or empty
vector-expressing SCC40 cells (FRNK and pWZL, respectively).
The subcellular localisation of endogenous FAK in transformed
cells was evaluated. As shown in Figure 1B, FAK mainly co-
localised with vinculin, a focal adhesion component, in pWZL cells
whereas it was also found in the cytoplasm in FRNK-SCC40 cells.
The retroviral-mediated expression of FRNK in SCC40 cells did not
substantially affect the overall levels of FAK but resulted in the
attenuation of FAK phosphorylation at Tyr397, a site whose
phosphorylation is associated with FAK-kinase activation. FRNK
also impaired the phosphorylation of FAK at Tyr861 and Tyr925,
two phospho-tyrosines that act as docking sites for protein
interactions crucial for FAK signalling function (Figure 1C). FRNK
expression did not affect the expression of paxillin, a
FAK-associated focal adhesion component. However, the phos-
phorylation of paxillin at Tyr118 decreased in FRNK cells as
compared with pWZL cells, consistent with a model of FAK as an
upstream modulator of focal adhesion components phosphoryla-
tion (Ruest et al, 2001). Stable pool populations of SCC38 cells
were also obtained and shown to behave as described for SCC40
cells (data not shown). Thus, FRNK expression provides a useful
tool to dissect the cellular mechanism by which FAK promotes
tumour cell phenotypes in HNSCC.
Nevertheless, given that expression of FRNK may cause effects
not related to the inhibition of FAK activity, we also examined the
effects of double-stranded siRNA oligonucleotides against FAK in
SCC40 and SCC38 cells. As shown in Figure 1C, FAK expression
was dramatically suppressed after 72 h of FAK siRNA transfection
in SCC40 cells, whereas control siRNA showed no effect. Similar
inhibition was also found in SCC8 cells treated with FAK siRNA
(data not shown). As expected, the levels of pTyr397-, pTyr861-, and
pTyr925-FAK were also markedly decreased. Suppression of FAK
expression by siRNA was also accompanied by decreased levels of
pTyr118-paxillin.
Taken together, the data showed that the two methodological
approaches, expression of FRNK and siRNA against FAK, inhibited
FAK-mediated signalling pathways in HNSCC-derived cells, and
were suitable tools to address the question as to whether FAK is
involved in HNSCC progression.
Inhibition of FAK expression or activity does not induce
changes in cell proliferation
Previous studies have shown that inhibition of FAK function by
FRNK results in decreased cell proliferation in nonneoplastic cells
(reviewed in (Craven et al, 2003; Parsons, 2003)). In addition, FAK
has been directly implicated in the promotion of tumour growth
and cell cycle progression in some tumour cells (Aguirre Ghiso,
2002; Hecker et al, 2002, 2004; van Nimwegen et al, 2005). To
investigate the possible role of FAK on cell proliferation of HNSCC
cells, MTS assays and cell counting were performed in SCC40 and
SCC38 cells expressing FRNK, siRNA against FAK, and in their
corresponding control cells. As shown in Figure 2, inhibition of
FAK activity by FRNK expression did not significantly affect the
cell growth rates. Similar data were obtained with siRNA-treated
cells (data not shown). Accordingly, the number of cells in each
phase of the cell cycle was similar in FRNK cells as compared with
pWZL cells, and in SCC cells transfected with FAK siRNA vs
control siRNA (data not shown). The apoptotic index was also
evaluated showing that both FRNK and FAK-siRNA expression did
not significantly affect cell viability in SCC cells (Figure 2C). These
data show that in the tumour background examined here FAK is
not important for cell proliferation.
Inhibition of FAK expression or activity impairs cell
attachment
As cell attachment to the extracellular matrix may contribute to
cancer metastasis, we investigated the effect of inhibition of the
FAK-mediated signal transduction on early cell adhesion of SCC40
and SCC38 cells. The experiments were conducted using three
different components of the extracellular matrix as substrates.
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Figure 1 Inhibition of FAK-mediated signalling by expression of FRNK or siRNA against FAK in HNSCC-derived SCC40 cells. (A) Confocal microscopy
images of SCC40 cells transiently transfected with pEGFP-FRNK and stained with phalloidin-TRITC to visualise actin organisation (GFP-FRNK, green
fluorescence; phalloidin-TRITC, red fluorescence). Images show transfected cells as well as nontransfected cells (marked with arrows), which served as
internal controls. As shown, FRNK is localised to focal contacts, docking sites of actin cytoskeleton to the extracellular matrix. Scale bars, 10 mm. (B) Confocal
microscopy images of SCC40 cells stably transfected with pWZL vector alone or pWZL-FRNK (FAK, green fluorescence; vinculin, red fluorescence). Images
show that FAK colocalise with vinculin at focal contact sites (marked with arrows) in pWZL-SCC40 cells whereas is mainly detected in the cytoplasm in
FRNK-SCC40 cells. Scale bars, 20 mm (pWZL-SCC40) and 15mM (FRNK-SCC40). (C) Western blot analysis showing expression of FRNK, pTyr397-FAK,
pTyr861-FAK, pTyr925-FAK, total FAK, pTyr118-paxillin and total paxillin in SCC40 cells stably transfected with pWZL-FRNK (FRNK) or treated with FAK-
siRNA. Cells infected with empty pWZL vector (pWZL) or transfected with control siRNA served as the control. The membranes were stripped and
reprobed with anti-a-tubulin antibody to assure even loading of proteins in each lane.
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Stable FRNK expression induced inhibition of cell attachment in
both SCC40 and SCC38 cells independently of the component of
the extracellular matrix used as a substrate (Figure 3A). The
percentage of inhibition in SCC40 cells ranged from about 25%
(when the cell adhesion assay was performed with collagen or
matrigel) to B60% (when fibronectin was used as a substrate). In
SCC38 cells, the highest rate of inhibition (B80%) was detected
when the cell adhesion assay was performed with matrigel. In the
same manner, cell adhesion to all substrates tested decreased in
SCC40 cells transfected with FAK siRNA as compared with cells
transfected with control siRNA (Figure 3B). The highest rate of
inhibition of cell attachment (B85% reduction vs control cells)
was observed in the presence of a reconstituted matrix gel whereas
adhesion to other substrates was inhibited about 50%. SCC38 cells
treated with FAK siRNA displayed about 25–30% inhibition of cell
adhesion to all substrates as compared with control cells. As
expected, cell adhesion to poly-HEMA, a polymer that acts as an
inhibitor of cell adhesion (Folkman and Moscona, 1978), was
negligible with all cells tested.
Inhibition of FAK-mediated signalling attenuates cell
migration and motility
To examine the effect of inhibition of FAK expression/activity on
cell migration, confluent monolayers of SCC40 or SCC38 cells
expressing FRNK, FAK siRNA or their respective controls were
artificially wounded by scraping them with a pipette tip and filmed
by time-lapse microscopy as they moved into the wound. As
shown in Figure 4B, the dominant negative FRNK decreased the
migratory potential of both SCC40 and SCC38 cells by B44 and
B35%, respectively as compared with pWZL cells. Similarly,
knock down of FAK expression by siRNA resulted in a 59% (SCC40
cells) or 41% (SCC38 cells) decrease in cell migration as compared
with cells transfected with nonspecific siRNA (Figure 4B).
Figure 4A shows a representative image of wound healing assay
performed in SCC40 cells transfected with control or FAK siRNAs.
Random linear cell motility was also assessed in cells carrying
inhibition of FAK-signalling. Cells expressing FRNK, FAK siRNA
or their respective control cells were plated on three different
substrates; fibronectin, collagen and matrigel, at low densities in
the presence of serum, and their random motility were monitored
by time-lapse microscopy. FRNK cells displayed reduced random
cell motility in the three substrates tested, varying from 79% of
inhibition on fibronectin, to 52% on collagen, and 59% on matrigel
for SCC40 cells (Figure 5A). The rate of inhibition was about 50%
in FRNK-SCC38 cells when the assay was performed with any of
the three substrates. Inhibition of FAK expression with siRNA in
SCC40 and SCC38 cells caused similar inhibitory effect on cell
motility (Figure 5B). In this case, the rates of inhibition were 47–
62 and 20–40% for SCC40 and SCC38 cells, respectively. Time-
lapse video microscopy also revealed that FRNK cells while
anchored to the substrate still exhibited broad membrane
protrusions that projected in multiple directions, a phenomenon
known as membrane ruffling (see Supplementary information). In
the case of cells transfected with FAK siRNA, besides refractory cell
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Figure 3 Inhibition of FAK expression or activity impaired cell
attachment in SCC40 and SCC38 cells. Cell adhesion on different
substrates was determined as described in Material and Methods in
SCC40 and SCC38 cells stably transfected with pWZL-FRNK (A) and cells
treated with FAK-siRNA (B) and compared with that measured in their
corresponding control cells (pWZL and control siRNA). Values are mean
of average±s.d. from four independent experiments done in triplicate.
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motility, we detected that they maintained a more elongated
morphology than control cells as they were either unable to release
their trailing edges or they simultaneously moved in opposite
directions (see Supplementary material). These phenotypes could
be due in part to an enhanced stability of focal contact structures
(Ilic et al, 1995).
Inhibition of FAK-mediated signalling pathway impairs
cell invasion and MMP-2 expression
SCC40 and SCC38 cells expressing FRNK and FAK siRNA were
analysed for their invasive potential through a B1-mm Matrigel
barrier compared with cells transfected with empty vector or
nonspecific siRNA. The data revealed that invasion was inhibited
with both, FRNK and FAK siRNA expression in SCC40 cells,
showing a 70 and 60% decrease in invasiveness, respectively
(Figure 6A and B). Similarly, inhibition of FAK activity or
expression in SCC38 cells resulted in 50 and 35% decrease of cell
invasion in FRNK- and FAK siRNA-expressing cells, respectively
(Figure 6A). We next determined whether FAK overexpression
increases the invasion potential of SCC cells. As shown in
Figure 6C, exogenously expressed FAK was localised in focal
adhesion sites in SCC38 cells transiently transfected with a yellow-
FAK (YFP-FAK) fusion protein. Matrigel invasion assays showed
that the invasion ability of SCC38 cells was significantly enhanced
(about twofold increase as compared with control cells) after
transient transfection with YFP-FAK (Figure 6C).
Because elevated expression, activation, and/or secretion of
matrix metalloproteinases (MMPs) in transformed cells can
promote an invasive phenotype (Deryugina and Quigley, 2006),
experiments were performed to determine whether enhanced
MMPs secretion and/or activity were associated with FAK-
mediated cell invasion. Conditioned media were collected from
FRNK or pWZL-SCC40 cells and subjected to gelatin zymography.
HT-1080 fibrosarcoma cells conditioned medium was used as
positive control for gelatin zymography. As shown in Figure 6D,
analysis of pWZL-conditioned media revealed the presence of a
major MMP protein activity that comigrated with pro-MMP-2
(72 kDa, gelatinase A). Low levels of both pro-MMP-9 (92 kDa,
gelatinase B) and activated-MMP-9 were also detected. Real time
RT–PCR analyses confirmed the reduced expression levels of
MMP-9 as compared with MMP-2 in SCC40 cells (MMP-2 mRNA
levels were about 30-fold higher than MMP-9 levels; data not
shown). Gelatinase zymography comparisons between FRNK and
pWZL cells revealed a strong inhibition of both MMP-2 and MMP-
9 protein expression in FRNK vs pWZL cells. Quantitative real time
RT–PCR was then performed to determine whether MMPs protein
inhibitions were also detected at the mRNA level. The data
revealed that, in accordance with the zymography analysis, MMP-2
and MMP-9 mRNA levels were, respectively, 62 and 85% lower in
FRNK cells as compared with pWZL cells (Figure 6D). These
results are consistent with recent studies showing a positive role
for FAK in mediating MMP-2 and MMP-9 secretion in other cell
types (Sein et al, 2000; Hauck et al, 2002; Zhang et al, 2002; Hsia
et al, 2003; Hu et al, 2006; Mitra et al, 2006).
We further determined whether lower levels of MMPs expres-
sion and secretion were also present in FRNK-SCC38 cells vs
pWZL-SCC38 cells. In these SCC cells, MMP-2 but not MMP-9
protein was detected by gelatin zymography. MMP-9 mRNA was
also undetectable by real time RT–PCR experiments. Similar to
SCC40 cells, FRNK expression in SCC38 cells resulted in inhibition
of MMP-2 expression detected at both, protein and mRNA levels
(Figure 6E). Expression of FAK siRNA in SCC38 cells also resulted
in a significant 3-fold reduction in MMP-2 mRNA levels (data not
shown). For unknown reasons, this last result could not be
reproduced in SCC40 cells.
We then determined whether MMP-2 could be involved in the
invasive potential of SCC cells by analysing the in vitro invasion
activity of SCC38 cells transiently transfected with either pcDNA3-
MMP-2 or empty vector. Matrigel invasion assays (Figure 6F)
revealed that a significantly greater number of MMP-2 transfected
cells invaded the Matrigel compared with the vector control cells.
FAK mRNA levels were not modified by MMP-2 overexpression
(data not shown). Taken together, these data show that MMP-2 is a
potential mediator of the FAK activity on cell invasion in SCC cells.
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Figure 5 Inhibition of FAK-mediated signalling inhibits cell motility in
SCC40 and SCC38 cells. FRNK- or pWZL-SCC40 and SCC38 cells (A)
and cells treated with FAK- or control-siRNA (B) were plated and images
taken every 15 min over a 12-h period. Quantification of linear cell motility
was determined by tracing the single cells using the cell-tracking software
(Kenetic Imaging Ltd). About 100 individual cells per cell line were analysed.
Values are mean of average±s.d. from three independent experiments
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Figure 4 Inhibition of FAK-mediated signalling pathway attenuates cell
migration in SCC40 and SCC38 cells. Wound healing assays were
performed in FRNK- and pWZL-expressing SCC40 and SCC38 cells, and
cells treated with FAK- or control-siRNA. (A) Representative images
captured with a  10 objective at the time of wounding (0 h) or 20 h after
wounding (20 h) in SCC40 cells transfected with control- or FAK-siRNA.
(B) Rate of front migration of cell monolayers analysed by time-lapse video
microscopy. At least 15 different fields were randomly chosen across the
wound length. Values are mean of average±s.d. from three independent
experiments.
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MMP-2 overexpression rescues FRNK inhibition of cell
invasion
To determine whether the inhibitory effect of FRNK in cell
invasion is mediated by MMP-2 reduced expression, human MMP-
2 was stably overexpressed in FRNK-expressing SCC40 and SCC38
cells. In SCC40 cells, pooled populations of FRNK-MMP-2
overexpressing cells showed increased levels of both MMP-2
protein, as detected by zymography analysis, and MMP-2 mRNA
levels, as detected by real time RT–PCR analyses (Figure 7A and
B). No changes in MMP-9 expression were detected in cells
overexpressing MMP-2. Western blot analysis showed that FAK
protein levels were not modified by MMP-2 overexpression in
FRNK SCC cells (data not shown). Overexpression of MMP-2
in FRNK cells did not induce changes in cell attachment but
slightly increased (1.5 fold increase vs FRNK cells) cell migration
(data not shown). Analysis of cell invasion through matrigel in
FRNK cells overexpressing MMP-2 showed a fourfold increase in
cell invasion as compared with FRNK cells (Figure 7C). To rule out
that the observed MMP-2 rescue of invasion was a nonspecific
effect, a pCEP-Puro plasmid containing either wild type MMP-2
cDNA or cDNA encoding for a catalitically inactive mutant MMP-2
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Figure 6 Inhibition of FAK-mediated signalling decreases cellular invasion through Matrigel and MMP-2 expression in SCC cells. (A and B) FRNK- or
pWZL-SCC cells and SCC cells treated with FAK- or control-siRNA were seeded in serum-free media in the upper chamber of Matrigel transwells. The
lower chamber was loaded with regular media supplemented with 10% fetal bovine serum and 5% BSA. After 24 h at 371C in 5% CO2, the top filter was
scraped, and invading cells were fixed and stained. (A) All invading cells were counted under  10 magnification. Values are mean of average±s.d. from a
representative experiment in a series of three done in triplicate. (B) Representative images from three separate experiments performed in SCC40 cells. (C)
SCC38 cells were transiently transfected with either pYFP-FAK or vector alone. Picture on the left is a representative confocal microscope image showing
that YFP-FAK fusion protein localises at focal sites. Scale bars, 10 mm. Matrigel invasion assays were performed 24 h after transfection. Representative images
from three separate matrigel invasion experiments performed in SCC38 cells transfected with either vector alone or pYFP-FAK are shown on the right. (D
and E), FRNK- or pWZL-SCC40 (D) and FRNK- or pWZL-SCC38 (E) cells were cultured in serum-free media. After 24 h, conditioned media and cells
were harvested for gelatinase zymography and MMPs mRNA quantification, respectively. HT-1080 fibrosarcoma cells conditioned medium was used as
positive control for zymography and migration standards. MMP-2 and MMP-9 transcripts were quantified using quantitative RT–PCR. The mean of relative
expression to cyclophilin A housekeeping gene of at least three independent experiments is shown. (F) Matrigel invasion assay was performed in SCC38
cells 24 h after transfection with either pcDNA3-MMP-2 or vector alone. Cell staining with crystal violet and subsequent extraction with dimethylsulphoxide
followed by spectrophotometry at 590 nm was performed for quantification of invading cells. All analyses were performed in triplicate. Representative
images from three separate experiments are shown.
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protein was stably transfected in FRNK-SCC40 cells. Transfected
cells showing equal levels of exogenous MMP-2 or mutMMP-2
(FRNK-CEP-MMP-2 and FRNK-CEPmutMMP-2 cells in Figure 7D)
were selected for analysis of cell invasion. Re-expression of MMP-
2, but not mutant MMP-2, in FRNK-cells notably increased cell
invasion to levels even higher than those detected in pWZL-SCC38
cells (Figure 7D).
Stably re-expression of MMP-2 or mutant MMP-2 was also
performed in FRNK-SCC38 cells. FRNK-CEP-MMP-2 pooled
clones showed increased levels of MMP-2 protein as compared
with FRNK-SCC38 cells (Figure 7F). Accordingly, increased MMP-
2 mRNA levels were detected in FRNK-CEP-MMP-2 and FRNK-
CEPmutFRNK cells as compared with pWZL- and FRNK-SCC38
cells (Figure 7E). No changes in FAK protein expression levels
were detected in cells overexpressing MMP-2 (data not shown). We
then analysed cell invasion through matrigel of FRNK-CEP-MMP-2
or FRNK-CEPmutMMP-2 cells and compared with that of pWZL-
and FRNK-SCC38 cells. The data showed that re-expression of
MMP-2, but not mutant MMP-2, in FRNK-cells notably increased
cell invasion to levels even higher than those detected in pWZL-
SCC38 cells (Figure 7G). These data support the conclusion that
FAK enhances in vitro SCC cell invasion activity by promoting
MMP-2 secretion.
DISCUSSION
We have previously reported that FAK is overexpressed in tumour
tissue samples and cell lines derived from HNSCC (Canel et al,
2006). Importantly, FAK overexpression in these carcinomas was
found in all stages of cancer progression, and it was associated
with the presence of lymph node metastasis, thus suggesting that
the deregulation of FAK may have an active role in the invasion
process of this type of tumors. It is well-documented that FAK
regulates cellular properties that could mediate its oncogenic
activity such as cell adhesion, proliferation, migration, invasion
and survival (Mitra and Schlaepfer, 2006; van Nimwegen and
van de Water, 2007). However, FAK seems to have different roles
in different tumour types contributing to different aspects of
malignancy (Hauck et al, 2002; Hsia et al, 2003; Han et al, 2004;
Mitra et al, 2006). The current study addressed the role of FAK in
mediating the processes that promote the invasive phenotype of
HNSCC. We inhibited FAK function in HNSCC cells by stable
expression of a dominant-negative variant of FAK, FRNK, or
transient expression of siRNA against FAK. Collectively, the data
suggest that FAK is an important mediator of cell attachment,
migration and invasion of HNSCC cells. We also show that FAK
enhances in vitro SCC40 and SCC38 cell invasion activity, at least
in part, by promoting MMP-2 secretion. Notably, these cancer cells
were not dependent on FAK for continued proliferation.
We show that inhibition of FAK signalling by expression of FAK
or FAK siRNA did not affect cell proliferation or survival in SCC40
and SCC38 cells. Several studies have indicated that FAK may have
a direct role in tumour growth and cell survival (Xu et al, 1996,
1998; Sonoda et al, 1999, 2000; Aguirre Ghiso, 2002; Hecker et al,
2002, 2004; van Nimwegen et al, 2005). However, there are also
published data showing that FRNK expression induces defects on
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Figure 7 MMP-2 overexpression rescues FRNK inhibition of cell invasion in SCC40 (A–D) and SCC38 (E–G) cells. Gelatinase zymography (A), MMP-2
mRNA quantification (B) and in vitro invasive assays (C) were performed in FRNK-, pWZL-, and FRNK-MMP-2-SCC40 cells as indicated in Figure 6. (D)
In vitro invasive assays performed in pWZL-, FRNK-, FRNK-CEP-MMP-2- and FRNK-CEPmutMMP-2-SCC40 cells. All invading cells were counted under
 10 magnification. Representative images from three separate experiments are shown. MMP-2 mRNA quantification (E), gelatinase zymography (F) and
matrigel invasion assays (G) were performed in pWZL-, FRNK-, FRNK-CEP-MMP-2- and FRNK-CEPmutMMP-2-SCC38 cells as indicated above.
Representative images of matrigel invasion assays in SCC38 cells are shown in (G). Experiments were repeated at least three times.
Role of FAK in head and neck squamous cell carcinomas
M Canel et al
1281
British Journal of Cancer (2008) 98(7), 1274 – 1284& 2008 Cancer Research UK
M
o
le
c
u
la
r
D
ia
g
n
o
st
ic
s
migration and/or invasion without effects on cell survival or
proliferation (Han et al, 2004; Mitra et al, 2006). Indeed,
impairment of cell proliferation and survival after FRNK expres-
sion in carcinoma cells has been associated with high levels of
overexpression (Xu et al, 2000; Golubovskaya et al, 2002; van
Nimwegen et al, 2005). Therefore, the contradictory effects on cell
growth or survival may be due to the levels of functional FAK in
the presence of FRNK or FAK siRNA. Alternatively, cell back-
ground differences may explain the resistance to inhibition of
these phenotypes.
Our data revealed that FRNK and FAK siRNA expression in
SCC40 and SCC38 cells induced decreased cell attachment, motility
and invasion. These phenotypes agree with the previous reported
data in other tumour cell types (Hauck et al, 2002; Schlaepfer et al,
2004; Mitra et al, 2005). Cellular migration is a complex process
that requires the precise cooperation of various signal transduction
pathways, which facilitate the regulated assembly and disassembly
of focal contacts to coordinate attachment and detachment of the
cell from the extracellular matrix. FAK has been found to be a key
regulator of cellular migration by initiating many of the signal
transduction pathways necessary for the assembly and turnover of
focal contacts. Although our in vitro data support a role for FAK in
the adhesion and migration processes involved in metastasis
formation, the exact downstream mediators of these effects remain
to be identified. The initial assembly of integrin-associated focal
adhesions requires FAK autophosphorylation on Tyr397 and
complex formation with Src. The FAK-Src signalling complex
functions to recruit and phosphorylate various FAK-associated
proteins including paxillin (Bellis et al, 1995; Schaller et al, 1995)
which participates in the coordination of integrin-mediated cell
motility (Klemke et al, 1998; Petit et al, 2000). We show here that
FRNK and siRNA against FAK inhibited Tyr397 phosphorylation of
FAK and Tyr118 phosphorylation of paxillin in HNSCC-derived
cells, which is accompanied by decreased cell motility. Never-
theless, impairment of cell motility in FRNK-expressing cells is
apparently accompanied by increased focal contact formation in
membrane ruffles thus suggesting that FRNK could still recruit
other signalling or effectors proteins required for assembly of focal
adhesion sites, and that decreased motility is due to impaired focal
adhesion turnover rather than to weakened adhesion assembly. A
role of FAK in cell movement acting preferentially in focal
adhesion turnover rather than in initial formation has been
previously suggested (Schlaepfer et al, 2004), and phosphorylation
of both FAK and paxillin contributes to turnover of focal contacts
(Turner, 2000; Brunton et al, 2005; Hamadi et al, 2005). Possibly,
the decreased cell motility caused by inhibition of FAK expression
or activity in HNSCC-derived cells is due to a decreased FAK
phosphorylation and FAK-induced paxillin phosphorylation and,
consequently, impaired focal adhesion turnover. Nevertheless, the
mechanism of action of FAK is complex and probably involves
multiple downstream signalling substrates.
Inhibition of FAK-mediated signalling pathway in SCC40 and
SCC38 cells also impairs cell invasion through matrigel. In
addition, transient overexpression of FAK in SCC cells increases
cell invasion. Several reports have shown that FAK can regulate cell
invasion not only by regulation of cell migration but also by the
modulation of matrix metalloproteinases that degrade extracellular
matrix barriers (Hsia et al, 2003; Mon et al, 2006b). We found that
MMP-2 and MMP-9 gene expression were greatly reduced by
FRNK expression in SCC40 cells. SCC38 cells express negligible
levels of MMP-9, as detected by both mRNA quantification and
gelatinase activity. Nevertheless, as observed in FRNK-SCC40 cells,
FRNK-SCC38 cells showed reduced levels of MMP-2 gene
expression and secretion. We also show here that MMP-2 is able
to promote cell invasion in SCC cells. Previous studies have
supported a role for FAK in MMP-2 secretion in response to
environmental factors (Sein et al, 2000; Zhang et al, 2002; Mon
et al, 2006b). Our studies show that FAK is implicated in MMP-2
gene expression leading to increased MMP-2 secretion in SCC
cells. Consistent with our findings, previous reports in v-Src
transformed fibroblasts and glioma cells (Hauck et al, 2002; Hu
et al, 2006) supported a role for FAK in promoting increased
MMP-2 gene expression. This FAK signalling pathway also seems
to operate in noncancerous cells (Segarra et al, 2005). There have
been reports linking other extracellular proteases, such as MMP-9
(Mon et al, 2006a), MMP-1 (Zeng et al, 2006) and uPA (Mitra et al,
2006) with FAK signalling in other tumour cell types, but until now
MMP-2 has not been reported to be involved. Therefore, distinct
downstream signalling pathways are active in a tumour cell type-
dependent manner. Evaluation of FAK-specific signalling in
different tumour types is therefore helpful for development of
the therapeutic strategies for cancers with high FAK expression
levels. In the present report, in addition to showing a reduced
expression of MMP-2 after FAK inhibition, we show that
overexpression of MMP-2 in FRNK-expressing HNSCC-derived
cell lines blocked FRNK-induced inhibition of cell invasion. The
reversion of the FRNK blockage of cell invasion was complete in
both cell lines, which reached levels of invasion 2- to 3-fold greater
than those observed in pWZL cells. Notably, a catalytically inactive
mutant form of MMP-2 did not reverse the effect of FRNK on cell
invasion in SCC38 and SCC40 cells. These data demonstrate that
the FRNK effects on cell invasion were mediated by the reduced
production of MMP-2. With the exception of transformed
fibroblasts (Hauck et al, 2002), re-expression of MMP-2 in cancer
cells with impaired function of FAK and subsequent rescue of
in vitro cell invasion defects has not been previously studied. The
extent to which MMP-2 contributes to FAK-mediated cell invasion
in other cancer cells remains unknown. Here we report, for the
first time in cancer cells, direct evidence that MMP-2 is an
important player of FAK-mediated cell invasion in HNSCC-derived
cells.
The biochemical mechanism involved in FAK-mediated regula-
tion of MMP-2 expression in SCC cells is presently unknown.
Previous reports have shown a functional link between FAK-ERK1/
2-JNK and MMP-2 expression in tumour and noncancerous cells
(Hauck et al, 2002; Segarra et al, 2005; Hu et al, 2006). In SCC cells,
the constitutive or EGF-induced levels of activated ERK1/2 and
JNK were not reduced by FRNK expression in comparison with
pWZL-SCC cells (data not shown). These preliminary data suggest
that the mediators of the FAK-MMP-2 pathway in HNSCC may
differ from those previously reported in other cancer cells. The
regulation of MMP-2 gene expression involves the convergence of
multiple trans-activators that seems to operate in a cell type-
specific manner (Yan and Boyd, 2007). The precise mechanism of
FAK-mediated regulation of MMP-2 in HNSCC is being further
explored.
Previous studies have determined that both MMP-2 and MMP-9
are associated with lymph node metastasis (Xie et al, 2004) and
poor outcome (Katayama et al, 2004) in HNSCC. In addition,
microarray gene expression studies on whole HNSCC tumour
samples have identified the overexpression of several MMPs
including MMP-2 (Nagata et al, 2003; Chung et al, 2004). Lastly,
MMP-2 is among the recently identified predictive genes that show
a positive correlation with lymph node metastasis (Roepman et al,
2006). In addition to the facts that FAK overexpression in primary
tumours of patients with HNSCC is associated with lymph node
metastasis and that there is an almost perfect correlation between
the expression levels of FAK found in the primary tumour and in
the corresponding metastasis, observations from these studies
support the importance of FAK as a mediator of metastatic HNSCC
cancer progression via the regulation of MMP-2 expression.
Collectively, the data reported here support the conclusion that
FAK enhances in vitro HNSCC cell invasion activity, at least in
part, by promoting both increased cell motility and MMP-2
secretion; thus, these data provide new insights into possible
therapeutic intervention strategies for HNSCC.
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